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Unconventional bacteria in urinary tract disease: Ureaplasma
urealyticum. Bladder-aspirate urine samples (N = 428) were cul-
tured for the presence of fastidious microorganisms. These sam-
ples were obtained from 190 patients with urinary tract disease or
symptoms suggesting infection of the urinary tract in whom
standard bacteriologic investigation had failed to indicate bacte-
rial infection. Ureaplasma urealyticum was recovered alone or
in association with other microorganisms from the bladder urine
of 75% of patients with reflux scarring and abnormal renal func-
tion. Ureaplasma organisms were localized to the upper urinary
tract in 80% of patients with bladder counts greater than 10
colony-forming units per ml. The results indicate that micro-
organisms not conventionally associated with urinary tract
infection are recoverable from the bladder urine of a high per-
centage of patients with so-called 'sterile pyelonephritis," in
which group of patients these microorganisms may contribute
to progressive renal disease.
Bactérle inhabituelle au cours de l'infection urinaire: Ureaplasma
urealyticum. Echantillons d'urine (N = 428) obtenus par ponction
vésicale ont été cultivés. Ces échantillons ont été obtenus de
190 patients atteints de symptômes suggérant l'infection urinaire
mais chez lesquels les etudes bactériologiques usuelles n'avaient
pas mis en evidence d'infection bactérienne. Ureaplasma ure-
alyticum a été obtenu seul ou en association avec d'autres micro-
organismes a partir de l'urine de 75% des malades atteints de
lesions de retlux et d'altération de Ia fonction rénale. Les Ure-
aplasmas étaient localisés au haut appareil urinaire chez 80% des
malades dont les numerations étaient supérieures a l0 cfu/ml.
Les résultats indiquent que les micro-organismes non habit-
uellement associés a l'infection urinaire peuvent être observes
dans l'urine vésicale dans un pourcentage élevé de malades at-
teints de soi-disant "pyélonéphrite sterile." Chez ces malades
ces micro-organismes peuvent contribuer a la progression de
l'affection rénale.
Despite many studies, the relationship between
urinary tract infection and progressive loss of renal
function in chronic atrophic pyelonephritis remains
uncertain. Although hydrodynamic damage to the
renal parenchyma following intrarenal refiux has
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been established as a cause of renal scarring [1, 2],
Ransley and Risdon [3] only found progressive
scarring when bacterial infection was present. Hod-
son Ct al [2] found that a single episode of refiux of
infected urine could produce extensive scarring, in-
dicating how difficult it may be to exclude microbial
infection as an etiologic factor in patients with pro-
gressive scarring and apparently sterile urine. This
difficulty is further emphasized by the finding that in
patients with progressive pyelonephritis the urine
may be sterile in spite of persistent pyuria, which
may disappear following antibiotic treatment [4].
Patients with bilateral chronic pyelonephritis may
progress to end-stage renal failure despite correc-
tion of factors that are known to contribute to
progression, such as overt bacterial infection,
vesicoureteric reflux, and hypertension [5]. This
apparent paradox led to an attempt to isolate micro-
organisms other than those conventionally asso-
ciated with urinary tract infection from the urine
of patients with renal disease. Some of the findings
obtained, with particular emphasis on urinary tract
colonization by Ureaplasma urealyticu,n, are re-
ported here.
Methods
Patients. Patients referred for consultation with a
range of urinary tract diseases and others with
symptoms such as dysuria and frequency suggest-
ing urinary tract infection were examined (see Table
2), the total number of subjects being 190. In each
case, midstream urine culture for conventional bac-
teria failed to yield a significant microorganism. No
other patient selection criteria was used. Patients
did not receive antibiotics during the 72-hour period
preceding urine collection. Urine samples from 35
apparently healthy individuals with no history of
urinary tract disease were examined as controls.
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Urine collection. Urine was collected from the
bladder by suprapubic aspiration (SPA) as follows:
A 20-gauge 3.5-inch disposable lumbar puncture
needle was introduced 1 inch above the symphysis
pubis via an area of skin that had been shaved and
disinfected with alcoholic chlorhexidine. A local
anaesthetic was not used. Urine was drawn into
sterile 20-mi syringes, which were capped with ster-
ile needles and sent to the laboratory. The first 20
ml of urine aspirated was used for microscopy.
Sterile gloves, mask, and gown were worn by the
operator during the collection procedure.
Culture methods
Culture methods are described below. Aerobic
cultures were set up in a laminar flow cabinet by an
operator wearing sterile gloves and gown. Anaero-
bic cultures were set up in an anaerobic chamber
with prereduced media. Cultures were incubated at
36° C. Culture media and saline diluent were pre-
pared with deionized glass-distilled water and ana-
lytical grade chemicals. Glassware and plastic con-
tainers were washed in deionized water.
Aerobic culture. Urine and 10-2 saline dilutions of
urine in volumes of 0.1 ml were spread over the sur-
face of horse-blood agar medium for colony counts.
Plates were incubated for 72 hours in a carbon diox-
ide incubator (95% air, 5% carbon dioxide).
Anaerobic culture. Blood agar medium was in-
oculated as described above and incubated anaero-
bically for 7 days.
Liquid culture. Urine in volumes of 0.1 and 1.0 ml
were added to 10 ml of chopped meat medium. Af-
ter 3, 10, 17, and 24 days of incubation, broth media
were subcultured aerobically and anaerobically
with blood agar medium. Subculture plates were in-
cubated for 7 days.
Cell-wall-defective bacteria. Antibiotic-free hy-
pertonic agar medium [6] was inoculated as follows:
0.1 ml of urine was spread over the surface of an agar
plate and incubated anaerobically for 14 days and I
ml of urine was incorporated in 20 ml of molten agar
and incubated as a deep culture for 28 days. Cul-
tures were examined at intervals for the presence of
conventional and L-type colonies.
Mycoplasmas. During initial stages, 0.5-ml vol-
umes of urine were added to S ml of ureaplasma
broth. After incubation for 24 hours, broth media
were subcultured on to standard ureaplasma agar
and horse-blood agar, which were incubated anae-
robically for 48 hours. Broth media were then in-
cubated for 14 days and examined for any color
change. After a number of patients had yielded pos-
itive cultures, an agar medium was developed that
would enable colony counts to be made. These
were obtained by placing 0.02-mi drops of urine and
102 saline dilution of urine on the surface of agar
plates without spreading. Absorption of drops was
facilitated by partially predrying plates for 15 to 20
mm in a laminar flow cabinet. Culture plates were
incubated anaerobically for 48 hours and examined
for colonies with a dissecting microscope (magnifi-
cation, X 6.3 to 32).
Identification of ureaplasma isolates. U. ure-
alyticum was identified on the basis of colonial size
and morphology, reduction of manganese salt,
urease production, failure to hydrolyse arginine,
sensitivity to erythromycin, and resistance to un-
comycin.
Culture media
Horse-blood agar. Four percent defibrinated
horse blood was incorporated in Columbia agar to
which was added 0.5 /.Lg!ml vitamin K and 5 mg/liter
haemin.
Standard ureaplasina agar. Basal medium was
composed of trypticase soy broth (BBL) (30 g/liter),
HEPES buffer (11.9 glliter), Oxoid agar No. 3 (12.25
g!liter); pH, 6.8. Complete medium was freshly pre-
pared each week by adding to the basal medium
20% horse serum (not inactivated), 0.1% urea, 1%
fresh yeast extract, 0.002% phenol red, 40 g/ml
ampicillin, 50 g/ml methicillin.
Ureaplasma colony count agar. The standard
medium was modified by the addition of 0.05%
manganous sulfate [7] and 500 sg/m1 carbenicillin.
Ureaplasma broth. Basal medium was composed
of 30 gfliter Trypticase soy broth (BBL), 5 g/liter
sodium chloride, 0.2 g/liter monobasic potassium
phosphate (pH, 6.0). Complete medium was freshly
prepared each week by adding to the basal medium
4% horse serum (not inactivated), 0.05% urea,
0.002% phenol red, 40 sg/m1 ampicillin, 50 jsg/ml
methicillin, and 500 g/ml carbenicillin.
Level of colonization of urinary tract. The prob-
able site of colonization of the urinary tract was de-
termined by the bladder washout method of Fairley
et al [8], modified as follows: Patients on a normal
fluid intake were asked to attend for the localization
test with a full bladder. A Foley catheter was
passed into the bladder, and after removal of 200 ml
of urine, a bladder sample was collected. The blad-
der was then drained and refilled with sterile saline
until the patient experienced moderate discomfort,
whereupon the bladder was emptied. This proce-
dure was repeated until 2 liters of saline had been
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used. A sample of washout fluid was collected mid-
way through the final bladder emptying. Four con-
secutive samples of urine were then collected at 10-
mm intervals through a freely draining catheter.
Leukocyte count. The degree of pyuria was quan-
tified by counting the number of leucocytes present
in urine sediment (concentrated 20-fold by centrifu-
gation) with a Fuchs-Rosenthal counting chamber.
Results
Bladder-aspirate urine samples (N = 428) from
190 patients were examined over 3 years. With the
special culture methods described, microorganisms
were recovered from the bladder urine of 54 (28%)
patients (Table 1). Of the 54 patients, 34 yielded a
growth of U. urealyticum, and in 17 of these anoth-
er microbial species was also present. The remain-
ing 20 culture-positive patients were ureaplasma-
free and are not considered further in this report. Of
the 35 controls, 2 yielded a growth of ureaplasmas,
and 2 yielded other microorganisms. Although the
frequency of ureaplasma isolation from the total pa-
tient group was not significantly different from that
observed in control subjects, a significantly in-
creased frequency of isolation was observed in par-
ticular patient groups (Table 2). Other mycoplasma
species (M. hominis, M. ferinentans, etc.) were not
isolated from any of these specimens, nor were L-
forms or bacterial variants recovered on hypertonic
medium. Most of the microorganisms isolated in the
study were not conventional urinary tract patho-
gens, the predominant species being U. ure-
alvticum.
Aspects of colonization of the urinary tract by U.
urealyticurn: Colony counts. Urine colony counts
were obtained from 21 patients and 2 control sub-
jects. Table 3 shows that counts from 17 patients
were <l0 colony-forming with (cfu) per ml, and
only 2 patients gave counts >l0 cfu/ml. Colony
counts from each of the 2 positive-control subjects
were <102 cfu/ml.
Duration of colonization. Thirty-four patients
gave a growth of ureaplasmas from bladder urine.
In 10 of these only a single sample was examined.
Table 4 shows that ureaplasmas were recoverable
from 17 of the remaining 24 patients over periods
ranging from 1 to 18 months. Most of these patients
have remained positive. Of 4 patients harboring ure-
Table 1. Frequency of isolation of microorganisms from bladder-aspirate urine samples of 190 patients and 35 control subjects
U. urealyticum U. urealyticum Bacteria
only and bacteria only No growth Total
no. % no. % no. % no. % no. %
Study group
Patients 17 9 17 9 20 11 136 72 190 101
lJrine samples 46 11 27 6 44 10 311 73 428 100
Control group
Control subjects 1 3 1 3 1 3 32 91 35 100
Urine samples 2 5 2 5 2 5 32 85 38 100
Table 2. Frequency of isolation of U. urealvticuin from patients classified according to their clinical diagnosis
No. tested No. yielding ureaplasmas Localization
results
Patients Patients
No. No. upper
Patient group Female Male Total Samples Female Male Total Samples studied tract
Chronic atrophic pyelonephritis
(refiux nephropathy) 33 5 38 123 14 0 14 (37%) 43 5 4
Recurrent urinary tract
infection (normal IVP) 18 0 18 39 6 0 6 (33%) 8 0 0
Renal papillary necrosis
(analgesic nephropathy) 8 3 11 31 1 1 2 (18%) 2 0 0
Renal calculi 9 7 16 33 1 1 2 (13%) 4 1 1
Glomerulonephritis
(biopsy proven) 43 34 77 153 9 0 9 (12%) 14 3 2
Medullary or polycystic
kidney disease 5 4 9 18 0 0 0 0 — —
Miscellaneous renal diseases
notincludedabove 13 8 21 31 1 0 1(5%) 2 1 1
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Table 3. Ureaplasma colony counts on 23 positive individuals
No. of samples
Colony counta
cfu/ml
in range indicated
Patients Controls
l05to 106 2 0
lO4to lO 2 0
lO3to 1O 11 0
lO2to 10 6 0
10'tolO2 0 2
Total 21 2
a Colony-forming units are abbreviated as cfu.
Table 4. Periods of time during which ureaplasmas were isolated
from the bladder urine a
Months culture
positive
No. of
patients
12to18 (18) 4
6to12 (12) 5lto6 (6) 8
Less than 1 (1) 7
Total 24
a Numbers in parentheses indicate number of months fol-
lowed.
aplasmas for longer than 12 months, 2 gave positive
cultures on eight occasions and the other 2 on five
occasions.
Level of urinary tract involvement. Localization
studies were carried out on 15 ureaplasma-positive
patients. In 5, the results were equivocal due to the
low counts of ureaplasmas in the bladder urine. Of
the remaining 10 patients, 8 were shown to harbor
ureaplasmas in the upper urinary tract. Table 5 sets
out the localization test results in 2 patients. Pa-
tient 1 was judged to have upper tract and patient 2
lower tract involvement. Renal biopsy material was
available from 7 of these 8 patients, and ure-
asplasmas were cultured from the renal tissue in 3.
In the 8th patient, bilateral nephrectomy specimens
yielded ureaplasmas in counts up to 106 g of tissue
from multiple sites in each kidney.
Isolation of ureaplasmas from different patient
groups. Table 2 shows the frequency of isolation of
ureaplasmas from different patient groups. Only pa-
tients with refiux scarring (P <0.01) and recurrent
urinary tract infection (P < 0.05) differed signifi-
cantly from the control group. Negative findings in
the other five patient groups provide a second "con-
trol" group with which to compare the reflux ne-
phropathy and chronic urinary tract infection
groups.
The frequency of isolation of ureaplasmas was as-
sessed in patients with reflux scarring in relation to
two parameters, namely plasma creatinine and 24-
hour urinary protein. Table 6 shows that 9 out of 12
patients with elevated plasma creatinine levels
yielded a growth of ureaplasmas from the bladder,
whereas only 4 of 23 patients with normal plasma
creatinine were positive (P < 0.01). There was no
comparable rise in ureaplasma isolations in patients
with raised urinary protein.
Association with pyuria. Leukocyte counts were
performed on 39 urine samples from the 17 patients
who yielded a growth of ureaplasmas only. Cell
counts > 10 cells/mi are judged to be elevated,
whereas counts < 10 cells/mi are considered nor-
mal in urine aspirated from the bladder. Pyuria was
present in 7 out of 8 patients, in whom only a single
urine sample was examined. Of the remaining 9 pa-
tients from whom multiple urine samples were ob-
tained, pyuria was present in 5 patients on each oc-
casion of sampling and in a further 3 patients on the
majority of samplings. In one patient, urine leuko-
cyte counts were within the normal range on two
samplings.
Association of ureaplasmas with other micro-
organisms. It was shown in Table 1 that 27 urine
samples from 17 ureaplasma-positive patients also
gave a growth of another microorganism. Of these
isolates, 22 were capnophilic gram-positive bacilli,
two were Staphylococcus epidermidis, one was
Lactobacillus brevis, one was Escherichia coli, and
one was S. faecalis. Ureaplasmas were isolated to-
gether with these additional microbial species on
each occasion of sampling in 12 of these patients,
whereas in the remaining 5 patients a second micro-
bial species was isolated from only a proportion of
ureaplasma-positive samples.
Discussion
Although urinary tract infection is a common
cause of morbidity, a definite causal relationship be-
tween the presence of bacteria in the urinary tract
and the scarring of chronic atrophic pyelonephritis
has not yet been established. The large majority of
studies set up to investigate this problem have been
concerned with bacterial species known to be asso-
ciated with acute infections of the urinary tract. Pa-
tients with apparent active chronic disease within
the kidney may, however, fail to yield a growth of
these "conventional" urinary tract pathogens from
the urine [4, 10, 1 1]. Several mechanisms have been
proposed to account for this paradox. It has been
suggested that the ongoing disease process is medi-
ated by persisting bacterial antigen within the renal
parenchyma [9, 10], but Holmgren et al [12] believe
that an autoimmune process is initiated involving
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renal tissue antigens that exhibit a degree of homol-
ogy with some E. coli serotypes. Mattman [13] and
others have suggested that conventional urinary
tract pathogens persist in a defective morphologic
or metabolic state such as L-forms or spheroplasts.
A simpler explanation would be the presence of mi-
croorganisms missed by conventional culture tech-
niques. McFadyen et a! [14] isolated fastidious bac-
teria from 11.5% of 2,000 needle-aspiration urine
samples from pregnant women, and Fairley et at
[11] reported anaerobic and other fastidious bac-
teria in a high percentage of patients with renal dis-
ease.
Only a limited number of studies have been un-
dertaken to examine the possibility that micro-
organisms other than those conventionally associat-
ed with urinary tract infection may be recoverable
from patients with "sterile pyelonephritis." The re-
sults obtained in the present study show that urine
samples from 54 out of 190 patients yielded a
growth of U. urealvticu,n and/or other microbial
species not conventionally associated with urinary
tract infection. To exclude contamination of sam-
ples as far as possible, only specimens of urine ob-
tained directly from the bladder by suprapubic aspi-
ration were cultured. It follows from these results
that terms such as "sterile pyuria" and "sterile
pyelonephritis" cannot be applied to patients on the
basis of standard urine culture results.
TableS. Results of localization tests from two representative
patients by the bladder washout method
Sample
Colony count
cfulrnl
Patient 1 Patient 2
Bladderurine
Saline washout
fluid
Postwashout urine
OtolOmin
l0to2Omin
20 to 30 mm
30to40min
1.5 )< 106
100
1.5x l0
6.6 x 10
2.6 x 10
3.6 x l0
1.2 X 10
200
<50
< 50
<50
< 50
In the present study, the only mycoplasma spe-
cies recovered was U. urealyticuin. This micro-
organism has been isolated from urine samples
alone, or in association with other microorganisms,
in a small number of earlier studies [15—18], al-
though in only two of these [15, 18] was SPA urine
examined. Ureaplasmas have also been recovered
from the urine of patients with primary hypogam-
maglobulinemia and severe chronic cystitis [19] and
from the joint fluid of patients with septic arthritis
and hypogammaglobulinemia [20, 21]. U. tire-
alyticum has also been shown capable of giving rise
to urethritis in males [22] and has been isolated from
patients with prostatitis and epididymitis [23]. Oth-
er workers have associated ureaplasmas with pelvic
inflammatory disease [24], reproductive failure [25—
27], chorioamnionitis [28—3 1], postpartum fever [28,
32], and low birth weights in infants [33, 34], al-
though the etiologic significance of ureaplasmas in
some of these disease states is not certain [35, 36].
Unlike conventional urinary tract pathogens,
which are capable of achieving high climax popu-
lations both in broth culture and in the urinary blad-
der, U. urealyticum seldom exceeds l0 to 108 cfu/
ml in broth culture. In the urine samples studied
here, the modal population density was only ap-
proximately l0 cfu/ml. Several factors limit the cli-
max population of ureaplasmas in broth cultures.
These include pH greater than 7.5 [37, 38], osmotic
pressure above 600 mOsm/kg [39], and high ammo-
nium ion concentration [38, 40]. It is possible that
one or more of these factors may result in even fur-
ther limitation in climax populations in urine. The
present results show that if the criteria of Kass [41]
for determining significant bacteriuria in midstream
urine had been applied, ureaplasma colonization of
the bladder and upper urinary tract would have
been missed in most patients.
The observation that ureaplasmas were present in
low numbers (50 cfu/ml) in the bladder urine of 2 out
of 35 presumed healthy individuals suggests that in
some instances these microorganisms may be pres-
ent in the urinary bladder without apparent patho-
logic significance. During the course of the study, it
Table 6. Frequency of isolation of ureaplasmas from patients with reflux scarring, with patients grouped according to plasma creatinine
and 24-hour urinary protein levels
Plasma creatinine
ry protein
>0.11
mmoles/liter
<0.11
mmoles/liter
24-hr Urina
> 0.2 g < 0.2 g
No. of ureaplasma-positive patients 9 4 7 6
No. of patients in group 12 23 17 20
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was found that ureaplasmas were repeatedly recov-
ered from the urine of some patients over many
months. Because patient isolates were not sero-
typed, it was not possible to determine in this study
whether repeated isolations indicated the per-
sistence of a particular strain or multiple episodes of
infection with different strains.
Localization studies indicate that ureaplasmas
were present in the upper urinary tract in 8 out of 10
patients with bladder counts higher than 5 x l0 cfu/
ml. When bladder urine counts were below this lev-
el, it was not possible to interpret localization test
results with confidence by the bladder washout
method. This high percentage of renal involvement
suggested on localization studies was confirmed in 4
patients by recovering ureaplasmas directly from
cultures of renal parenchyma. This finding is impor-
tant in regard to the possible etiologic significance
of ureaplasmas in renal disease, and further studies
are being undertaken to attempt to identify the sites
of ureaplasma localization within the kidney by us-
ing labeled ureaplasma specific antibody.
Table 2 shows that ureaplasmas were recovered
from the bladder urine of patients in several disease
categories. The highest percentage was obtained
from patients with renal scarring and impaired renal
function. This association warrants further investi-
gation to determine whether ureaplasma infection is
causally related to progressive renal damage. Evi-
dence from this study indicates that a group of pa-
tients deemed to have "sterile pyelonephritis" on
the basis of conventional bacteriologic tests har-
bored U. urealyticum in the upper urinary tract.
The results are open to only a limited number of
interpretations. It is possible that U. urealyticum is
a normal inhabitant of the urinary bladder in healthy
individuals and has no pathologic significance and
that recovery of ureaplasmas from patients merely
reflects the incidence of colonization in healthy
populations. The marked difference in prevalence in
patients with scarred kidneys and in healthy con-
trols makes this explanation unlikely. A second
possible explanation of the results is that urea-
plasmas are capable of colonizing previously dam-
aged urinary tracts or the urinary tracts of individ-
uals with diminished host resistance, but that such
colonization is without pathologic significance. Fi-
nally, it is possible that ureaplasmas may infect nor-
mal or compromised urinary tracts and may cause
or contribute to progressive renal disease. Any of
these interpretations could substantially alter our
present understanding of microbial-urinary tract
relationships.
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